Our voices were heard! Congress passed a final Fiscal Year 2020 (FY20) appropriations package that shows their continued, bipartisan commitment to funding medical research.
The FY20 funding includes:
- $41.68 billion for the National Institutes of Health (NIH), an increase of $2.6 billion, or 6.7%, above FY19
- $6.245 billion for the National Cancer Institute (NCI), a $501.5 million increase
- $110 million for the Peer-Reviewed Cancer Research Program (PRCRP) under the Department of Defense, a $20 million increase, and brain cancer and pediatric brain tumors are once again included as eligible topics for funding
- $30 million in targeted funding for the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act
- $50 million in new funding for the White House’s Childhood Cancer Data Initiative
- Increases to every Institute and Center within NIH to continue investments in innovative research to advance fundamental knowledge and speed the development of new therapies, diagnostics, and preventive measures to improve the health of all Americans.
This is a major victory for all who care about finding better treatments and cures for a variety of diseases, including brain tumors. We look forward to working with the funded institutions and programs to prioritize brain tumor research as part of their research portfolios.
National Brain Tumor Society — and YOU, our dedicated volunteer advocates — are a powerful voice that influenced this important budget decision. The new money will be spent in labs to discover new potential treatments, as well as for clinical trials to evaluate potential therapies, and for innovation in care models aimed at helping children with brain tumors.
Please thank your members of Congress and let them know that their commitment to research funding is important to you.